Data gathered: October 14
Alternative Data for Amphastar P
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 78 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,126 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Amphastar P
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
| Price | $49.29 |
| Target Price | Sign up |
| Volume | 283,010 |
| Market Cap | $2.33B |
| Year Range | $36.99 - $56.02 |
| Dividend Yield | 0% |
| PE Ratio | 15.1 |
| Analyst Rating | 60% buy |
| Industry | Biotechnology |
In the news
 |
Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?October 11 - Yahoo |
 |
Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock OptionsOctober 2 - Yahoo |
Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2October 1 - GuruFocus |
|
 |
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returnsSeptember 19 - Yahoo |
Amphastar Pharmaceuticals Inc (AMPH) Trading 2.97% Higher on Sep 13September 12 - GuruFocus |
|
Bullish Two Hundred Day Moving Average Cross - AMPHSeptember 12 - Market News Video |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 182M | 87M | 95M | 38M | 52M | 0.940 |
| Q1 '24 | 172M | 82M | 90M | 43M | 62M | 1.040 |
| Q4 '23 | 178M | 82M | 96M | 36M | 57M | 0.880 |
| Q3 '23 | 181M | 72M | 108M | 49M | 83M | 1.150 |
| Q2 '23 | 146M | 73M | 73M | 26M | 36M | 0.650 |
Insider Transactions View All
| Zhou Rong filed to sell 118,388 shares at $48.3. September 17 '24 |
| Petersen Floyd F. filed to sell 75,409 shares at $46.5. September 6 '24 |
| Zhou Rong filed to sell 118,388 shares at $48.4. August 27 '24 |
| PRINS RICHARD K filed to sell 33,971 shares at $43.1. August 13 '24 |
| PETERS WILLIAM J filed to sell 94,103 shares at $44.2. August 2 '24 |
Similar companies
Read more about Amphastar P (AMPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Amphastar P?
The Market Cap of Amphastar P is $2.33B.
What is Amphastar P's PE Ratio?
As of today, Amphastar P's PE (Price to Earnings) ratio is 15.1.
What is the current stock price of Amphastar P?
Currently, the price of one share of Amphastar P stock is $49.29.
How can I analyze the AMPH stock price chart for investment decisions?
The AMPH stock price chart above provides a comprehensive visual representation of Amphastar P's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amphastar P shares. Our platform offers an up-to-date AMPH stock price chart, along with technical data analysis and alternative data insights.
Does AMPH offer dividends to its shareholders?
As of our latest update, Amphastar P (AMPH) does not offer dividends to its shareholders. Investors interested in Amphastar P should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Amphastar P?
Some of the similar stocks of Amphastar P are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.